AlgaeCytes uses a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA.
AlgaeCytes has raised $12.6M in total funding. The most recent round was Grant. The last funding was announced in January 2022.
AlgaeCytes's investors include Deepbridge Capital, Federal Ministry for Economic Affairs and Energy (BMWi).
AlgaeCytes is headquartered in Sandwich, United Kingdom.
AlgaeCytes uses a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA.
AlgaeCytes is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AlgaeCytes — Funding & Investors." VCBacked, January 14, 2022, https://www.vcbacked.co/company/algaecytes. Accessed November 12, 2026.
VCBacked. (2022). AlgaeCytes — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/algaecytes
{{cite web |title=AlgaeCytes — Funding & Investors |url=https://www.vcbacked.co/company/algaecytes |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at AlgaeCytes? Request a listing update